Immunotherapy. 2012;4(9):939-945. The percentage of patients achieving complete clearance of their AKs in the 5-FU group was 19, 28.2 and 52.6% in the 1-, 2- and 4-week treatment groups, respectively.
The medication names of the current FDA-approved topical agents for the treatment of AK including Carac® (Sanofi-Aventis, NJ, USA), Efudex ... allowed the application of additional treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback